SCHEMBL8604002

SCHEMBL8604002

C=C(c1ccc2ccc(Cl)cc2n1)c1ccccc1CCl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.38
▸ NR4A2 P43354 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.33
▸ SLC6A4 P31645 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ TP53 P04637 2/20 0.32
▸ AR P10275 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961177 0.81 ALDH1A1 (0.46) CNR2POLBNPC1RAB9AKMT2A
SCHEMBL5816742 0.75 ALDH1A1 (0.46) SLC6A4MAPTALDH1A1KDM4ELMNA
SCHEMBL2020026 0.72 TDP1 (0.33) CNR2NR4A2NPC1KMT2ASMN1; SMN2
SCHEMBL18463776 0.71 NR4A2 (0.43) CNR2NR4A2POLBNPC1KMT2A
SCHEMBL9757049 0.70 NR4A2 (0.41) CNR2NR4A2KMT2ASMN1; SMN2MAPT
SCHEMBL9335423 0.70 PRSS1 (0.38) CNR2NR4A2NPC1RAB9ASMN1; SMN2
SCHEMBL8414693 0.70 RAB9A (0.50) CNR2NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL5810767 0.69 MEN1 (0.34) POLBNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL3228023 0.69 CNR2 (0.43) CNR2NR4A2POLBNPC1RAB9A
SCHEMBL8617775 0.68 MGAM (0.49) CNR2NPC1RAB9AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756518-A EXHIBITS ANTILEUKOTRIENIC ACTION AND ANTIHISTAMINIC ACTION; IS USEFUL IN TREATMENT OF ASTHMA KOWA CO., LTD. (JP) 1998-05-26 — — US disclosed
Send feedback